Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Cyclically Adjusted Book per Share: ¥15.30 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600436 Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
86 GF Score
Price ¥140.02
GF Value ¥172.71
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhangzhou Pientzehuang Pharmaceutical Co SHSE:600436 -4.51% 86 Cyclically Adjusted Book per Share is ¥15.30 as of Mar. 2026. GuruFocus rates SHSE:600436 with a GF Score™ of 86/100 and a GF Value™ of ¥172.71 (Modestly Undervalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhangzhou Pientzehuang Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥25.215. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥15.30 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhangzhou Pientzehuang Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 15.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhangzhou Pientzehuang Pharmaceutical Co was 21.80% per year. The lowest was 16.60% per year. And the median was 20.35% per year.

As of today (2026-07-20), Zhangzhou Pientzehuang Pharmaceutical Co's current stock price is ¥140.02. Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥15.30. Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 9.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhangzhou Pientzehuang Pharmaceutical Co was 66.90. The lowest was 7.06. And the median was 22.27.


Zhangzhou Pientzehuang Pharmaceutical Co  (SHSE:600436) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=140.02/15.30
=9.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhangzhou Pientzehuang Pharmaceutical Co was 66.90. The lowest was 7.06. And the median was 22.27.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhangzhou Pientzehuang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.68 9.31 10.97 12.79 14.77

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.31 13.74 14.27 14.77 15.30

SHSE:600436 vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600436
86GF Score
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhangzhou Pientzehuang Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhangzhou Pientzehuang Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=25.215/116.3033*116.3033
=25.215

Current CPI (Mar. 2026) = 116.3033.

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 5.333 101.400 6.117
201609 5.640 102.400 6.406
201612 5.790 102.600 6.563
201703 6.168 103.200 6.951
201706 6.236 103.100 7.035
201709 6.691 104.100 7.475
201712 6.856 104.500 7.630
201803 7.357 105.300 8.126
201806 7.340 104.900 8.138
201809 7.805 106.600 8.515
201812 8.312 106.500 9.077
201903 9.133 107.700 9.863
201906 9.747 107.700 10.526
201909 10.408 109.800 11.024
201912 10.991 111.200 11.495
202003 11.711 112.300 12.128
202006 11.581 110.400 12.200
202009 12.475 111.700 12.989
202012 13.032 111.500 13.593
202103 13.972 112.662 14.424
202106 14.004 111.769 14.572
202109 15.489 112.215 16.053
202112 16.087 113.108 16.542
202203 17.123 114.335 17.418
202206 16.942 114.558 17.200
202209 18.062 115.339 18.213
202212 18.779 115.116 18.973
202303 20.076 115.116 20.283
202306 20.105 114.558 20.411
202309 21.560 115.339 21.740
202312 22.171 114.781 22.465
202403 23.757 115.227 23.979
202406 22.657 114.781 22.958
202409 23.240 115.785 23.344
202412 23.655 114.893 23.945
202503 25.298 115.116 25.559
202506 24.240 114.907 24.534
202509 23.988 115.471 24.161
202512 24.099 115.832 24.197
202603 25.215 116.303 25.215

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥15.30 mean?
Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) has a Cyclically Adjusted Book per Share of ¥15.30 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors.
Is Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhangzhou Pientzehuang Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥15.30. Overall, Zhangzhou Pientzehuang Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
Zhangzhou Pientzehuang Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥15.30 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhangzhou Pientzehuang Pharmaceutical Co and its competitors. Zhangzhou Pientzehuang Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥15.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhangzhou Pientzehuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥172.71, compared to a current price of ¥140.02 — trading 18.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥15.30. Zhangzhou Pientzehuang Pharmaceutical Co's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436), the current Cyclically Adjusted Book per Share is ¥15.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Overvalued in 2026?

Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥140.02 is trading 18.9% below its estimated GF Value™ of ¥172.71. GuruFocus considers Zhangzhou Pientzehuang Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600436:

  • Cyclically Adjusted Book per Share: ¥15.30
  • GF Value™: ¥172.71 vs. price of ¥140.02 (18.9% below fair value)
  • GF Score™: 86/100 with 9 warning signs

No single metric tells the full story. See the SHSE:600436 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhangzhou Pientzehuang Pharmaceutical Co Business Description

Address No. 1, Hupo Road, Xiangcheng District, Fujian Province, Zhangzhou, CHN, 363000
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).
86GF Score

Get the complete analysis for SHSE:600436

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥140.02
Price
¥172.71
GF Value